Race and outcomes: is this the end of the beginning for minority health research?
Brawley
O W
OW
Freeman
H P
HP
D001741:Black or African American / Q000706:statistics & numerical data*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D015510:Clinical Medicine / Q000592:standards; D002986:Clinical Trials as Topic / Q000592:standards; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000208:ethnology* / Q000601:surgery; D006801:Humans; D009316:National Institutes of Health (U.S.); D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis; D015996:Survival Rate; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D044465:White People / Q000706:statistics & numerical data*
D000970:Antineoplastic Agents